Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?

Jaydeep Bhat; Léonce Kouakanou; Christian Peters; Zhinan Yin; Dieter Kabelitz

doi:10.3389/fimmu.2018.00512

Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?

Front Immunol. 2018 Mar 13:9:512. doi: 10.3389/fimmu.2018.00512. eCollection 2018.

Authors

Jaydeep Bhat¹, Léonce Kouakanou¹, Christian Peters¹, Zhinan Yin², Dieter Kabelitz¹

Affiliations

¹ Institute of Immunology, University of Kiel, Kiel, Germany.
² The First Affiliated Hospital, Biomedical Translational Research Institute, Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou, China.

No abstract available

Keywords: Bromodomain and ExtraTerminal domain; DNA methylation; checkpoint inhibitors; gamma delta T cells; histone acetylation; immunotherapy; natural-killer group 2 member D; programmed death 1.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cell Plasticity
Epigenesis, Genetic
Humans
Immunotherapy*
Intraepithelial Lymphocytes / immunology*